Grow Pharma (Grow Group)

What it is

Grow Pharma is a UK company that imports and distributes cannabis-based products for medicinal use (CBPMs) for prescription by specialist doctors in the United Kingdom. Since the November 2018 rescheduling of cannabis-based medicinal products under the Misuse of Drugs Regulations, specialist doctors on the General Medical Council's Specialist Register have been able to prescribe unlicensed CBPMs to patients, and a small number of importers and distributors handle the regulated logistics of getting those products from overseas producers into UK pharmacies ^[1][2]. Grow Pharma operates in that distribution layer rather than as a clinic or consumer-facing brand. Strong evidence

The company has appeared in UK trade reporting in connection with the import of medical cannabis flower and oils for patients seen at private specialist clinics ^[3].

Ownership and structure

Grow Pharma Ltd is a UK-registered company and forms part of what public materials and trade press describe as the Grow Group, which also includes Grow Pharmacy, a dispensing operation ^[3]. Detailed shareholder structures, financial filings and any external investors should be checked directly on the UK Companies House register, which holds the authoritative public record of UK company ownership, officers and accounts ^[4]. We have not independently audited those filings for this profile, and readers relying on claims about ownership, control or financial position should consult Companies House directly. No data

Market and category focus

Grow Pharma's stated focus is the UK private medical cannabis market — that is, patients who receive a private prescription for a CBPM from a specialist doctor and have it dispensed by a pharmacy. The UK NHS very rarely funds cannabis-based prescriptions outside of a small number of licensed products (such as Epidyolex and nabiximols) and severe paediatric epilepsy cases, so most CBPM prescribing happens in the private sector ^[1][2][5].

Within that market, importers like Grow Pharma sit between overseas licensed producers (typically in jurisdictions such as Canada, Australia, Portugal, the Netherlands, Germany, Denmark or Israel) and UK pharmacies. They handle Home Office import licensing, MHRA-regulated wholesale distribution, and storage of controlled drugs ^[2]. Strong evidence

Products and services

Because the products distributed under this layer of the supply chain are unlicensed specials, they are not promoted to the public and individual SKUs change over time as supply agreements with overseas producers evolve. Grow Pharma is reported to distribute dried cannabis flower and cannabis oil preparations to UK pharmacies that dispense against specialist prescriptions ^[3].

This profile does not list specific cultivars, brand partners or product names, because such lists go out of date quickly and could be read as a recommendation. Patients should rely on their prescriber and dispensing pharmacy for the current product list, certificate of analysis (COA), and storage and dosing guidance. Weak / limited

Reputation, controversies and regulatory context

We are not aware of any major published regulatory enforcement actions against Grow Pharma at the time of this profile, but absence of reporting is not the same as a clean record, and our search is not exhaustive. The UK medical cannabis sector as a whole has faced ongoing criticism over patient access, NHS funding limits, and slow progress on clinical evidence generation, rather than over any specific importer ^[1][5]. Weak / limited

Readers should also note that the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), maintains public registers of wholesale dealer's licences and manufacturer's licences; the most reliable way to verify the current regulatory status of any UK pharmaceutical distributor is to search those registers directly ^[6].

Availability and legal-market notes

Products distributed by Grow Pharma are only legally accessible in the UK through a prescription from a specialist doctor and dispensing by a registered pharmacy. They are not available over the counter, are not sold direct to consumers, and cannot be lawfully imported by individuals from outside the UK supply chain ^[1][2]. Travelling abroad with prescribed CBPMs is governed by separate Home Office and destination-country rules.

Nothing in this article should be read as advice to seek out a specific brand or product — prescribing decisions are clinical and patient-specific.

What to verify before relying on brand claims

If you are a patient, prescriber, journalist or investor evaluating Grow Pharma or any similar UK medical cannabis distributor, we'd suggest checking the following primary sources rather than trusting marketing copy:

• Companies House for current company status, directors, filed accounts and group structure ^[4].
• MHRA public registers for current wholesale dealer's licence and any compliance actions ^[6].
• Home Office guidance on controlled drug licensing for importers ^[2].
• The prescribing clinic and dispensing pharmacy for the actual product currently being supplied, its country of origin, and its certificate of analysis.
• NICE and NHS England guidance for the (limited) circumstances in which CBPMs are funded on the NHS ^[5].

Profile last checked: 2024. Details such as ownership, product range and licensing status can change; re-verify before relying on anything here for a clinical, commercial or editorial decision.

Sources

How this page was made